102 related articles for article (PubMed ID: 2031940)
1. Localization and regulation of epidermal 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity by barrier requirements.
Proksch E; Elias PM; Feingold KR
Biochim Biophys Acta; 1991 Apr; 1083(1):71-9. PubMed ID: 2031940
[TBL] [Abstract][Full Text] [Related]
2. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements.
Proksch E; Elias PM; Feingold KR
J Clin Invest; 1990 Mar; 85(3):874-82. PubMed ID: 2312730
[TBL] [Abstract][Full Text] [Related]
3. Epidermal HMG CoA reductase activity in essential fatty acid deficiency: barrier requirements rather than eicosanoid generation regulate cholesterol synthesis.
Proksch E; Feingold KR; Elias PM
J Invest Dermatol; 1992 Aug; 99(2):216-20. PubMed ID: 1629633
[TBL] [Abstract][Full Text] [Related]
4. Effect of cutaneous permeability barrier disruption on HMG-CoA reductase, LDL receptor, and apolipoprotein E mRNA levels in the epidermis of hairless mice.
Jackson SM; Wood LC; Lauer S; Taylor JM; Cooper AD; Elias PM; Feingold KR
J Lipid Res; 1992 Sep; 33(9):1307-14. PubMed ID: 1402399
[TBL] [Abstract][Full Text] [Related]
5. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis.
Harris IR; Farrell AM; Grunfeld C; Holleran WM; Elias PM; Feingold KR
J Invest Dermatol; 1997 Dec; 109(6):783-7. PubMed ID: 9406821
[TBL] [Abstract][Full Text] [Related]
6. [The epidermis as metabolically active tissue: regulation of lipid synthesis by the barrier function].
Proksch E
Z Hautkr; 1990 Mar; 65(3):296-300. PubMed ID: 2187311
[TBL] [Abstract][Full Text] [Related]
7. [Regulation of the epidermal permeability barrier by lipids and hyperproliferation].
Proksch E
Hautarzt; 1992 Jun; 43(6):331-8. PubMed ID: 1628964
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis.
Menon GK; Feingold KR; Mao-Qiang M; Schaude M; Elias PM
J Invest Dermatol; 1992 Feb; 98(2):209-19. PubMed ID: 1732385
[TBL] [Abstract][Full Text] [Related]
9. Barrier function regulates epidermal lipid and DNA synthesis.
Proksch E; Holleran WM; Menon GK; Elias PM; Feingold KR
Br J Dermatol; 1993 May; 128(5):473-82. PubMed ID: 8504036
[TBL] [Abstract][Full Text] [Related]
10. Topical mevalonic acid stimulates de novo cholesterol synthesis and epidermal permeability barrier homeostasis in aged mice.
Haratake A; Ikenaga K; Katoh N; Uchiwa H; Hirano S; Yasuno H
J Invest Dermatol; 2000 Feb; 114(2):247-52. PubMed ID: 10651982
[TBL] [Abstract][Full Text] [Related]
11. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function.
Kim M; Jung M; Hong SP; Jeon H; Kim MJ; Cho MY; Lee SH; Man MQ; Elias PM; Choi EH
Exp Dermatol; 2010 Jun; 19(6):501-10. PubMed ID: 19703225
[TBL] [Abstract][Full Text] [Related]
12. Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements.
Holleran WM; Gao WN; Feingold KR; Elias PM
Arch Dermatol Res; 1995; 287(3-4):254-8. PubMed ID: 7598529
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice.
Ottey KA; Wood LC; Grunfeld C; Elias PM; Feingold KR
J Invest Dermatol; 1995 Mar; 104(3):401-4. PubMed ID: 7861009
[TBL] [Abstract][Full Text] [Related]
14. Decreased epidermal lipid synthesis accounts for altered barrier function in aged mice.
Ghadially R; Brown BE; Hanley K; Reed JT; Feingold KR; Elias PM
J Invest Dermatol; 1996 May; 106(5):1064-9. PubMed ID: 8618040
[TBL] [Abstract][Full Text] [Related]
15. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
Schuler LA; Toaff ME; Strauss JF
Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
[TBL] [Abstract][Full Text] [Related]
16. The regulation of epidermal lipid synthesis by permeability barrier requirements.
Feingold KR
Crit Rev Ther Drug Carrier Syst; 1991; 8(3):193-210. PubMed ID: 1954650
[TBL] [Abstract][Full Text] [Related]
17. Activation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase during high fat diet feeding.
Wu N; Sarna LK; Hwang SY; Zhu Q; Wang P; Siow YL; O K
Biochim Biophys Acta; 2013 Oct; 1832(10):1560-8. PubMed ID: 23651731
[TBL] [Abstract][Full Text] [Related]
18. Differential activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase in zones of the adrenal cortex.
Kubo M; Strott CA
Endocrinology; 1987 Jan; 120(1):214-21. PubMed ID: 3023027
[TBL] [Abstract][Full Text] [Related]
19. The lovastatin-treated rodent: a new model of barrier disruption and epidermal hyperplasia.
Feingold KR; Man MQ; Proksch E; Menon GK; Brown BE; Elias PM
J Invest Dermatol; 1991 Feb; 96(2):201-9. PubMed ID: 1991980
[TBL] [Abstract][Full Text] [Related]
20. Increase in serum and bile cholesterol and HMG-CoA reductase by lovastatin in rats.
Yamauchi S; Linscheer WG; Beach DH
Am J Physiol; 1991 Apr; 260(4 Pt 1):G625-30. PubMed ID: 2018137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
